3rd Quarter - Report
THE UNITED STATES PHARMACOPEIAL CONVENTION for THE UNITED STATES PHARMACOPEIAL CONVENTION
Income
—
Expenses
$50,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 2364 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions related to supply chain risk assessment. The Pandemic and All-Hazards Preparedness Reauthorization Act: Provisions related to a more resilient pharmaceutical supply chain. Issues related to the Food and Drug Administration's Regulation of cannabidiol products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M. HILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.